Commercialization: Page 109
-
PharmaVoice Team/PharmaVoice
The New Detail: Creating Value
Preserving access for representatives with physicians and creating win-win relationships are two major challenges facing the industry, but opportunities exist for creative people committed to healthcare and the value of medicine. The new reality of medical practice is that time is a very limited ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
HBA Unleashes the Power of Being
Becoming an Agent of Change Was the Focus of the 2005 Leadership Conference by Marie Tartaglio, M.Ed., Director, Training & Learning Strategy, Scientific Advantage LLC, and Donna Ramer, President, StrategCations Inc., Member, HBA Board of Directors “Successful leaders are adept at mastering c...
By Marie Tartaglio • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ringing in a new year of change Taren Grom, Editor of PharmaVOICE, and Mary Alice Raudenbush, VP of Regulatory Affairs at Endo Pharmaceuticals, share a moment during the recent HBA Leadership Conference in Baltimore, the focus of which was becoming an agent of change. HBA Leadership Conference Ri...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Alzheimer's Disease: Untangling the Brain's Mystery
By Cynthia Borda As the population ages, the prevalence of Alzheimer’s disease (AD) is expected to increase. But there is no real way to diagnose the disease and drugs currently on the market only treat the symptoms of Alzheimer’s. At the same time, analysts say there is tremendous opportunity fo...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Competitive Intelligence: The Eyes and Ears of the Industry
The need to gain a competitive advantage has never been greater, and competitive-intelligence (CI) teams are evolving to meet the industry’s current and future challenges. Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the fact...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
In the Clinic: Trials & Tribulations
Stakeholders involved with drug development and the clinical-trial process are rising to the challenges to improve efficiencies, reduce costs, and accelerate time lines. Systematic elegant approaches borrowing from areas such as intelligence analysis are at hand. Enhanced product characterization...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Thought Leaders
Thought Leaders Listed in Alphabetical Order December 2005 Year in Preview 2006 Meredith Abreu. VP of Research, Manhattan Research LLC, New York; Manhattan Research is a provider of health and pharmaceutical marketing research and strategic analysis. For more information, visit manhattanresearch....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Featured Experts
Featured Experts Indexed by Section Introduction Introduction Murray Aitken. IMS Health Rudy Bakalov, CISSP. Ernst & Young LLP Daniel B. Carr, M.D. Javelin Pharmaceuticals Inc. Mark A. Goldberg, M.D. Perceptive Informatics, Parexel International Cort Grey. Dendrite Clinical Travis Hollingswor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
In the Boardroom
From defining and redefining organizational business models for big pharma, biotech, and emerging pharma to tactical decisions related to developing generic defense strategies to improving communications and corporate reputation plans to grappling with technology issues, today’s pharmaceutical le...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Tracking the Trends: The Industry Across Sectors
From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry executives, representing all of the major sectors of the life-sciences industry, provide their insights on the ...
By Taren Grom and Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
About EDC: Michael Minor says EDC has a significant place in global data management strategies. Year In Preview From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Year in Preview 2006 More than 135 experts talk about the industry’s future The Forum for the Industry Executive December 2005 Special Issue www.pharmavoice.com December 2005 PharmaVoice Volume 5 • Number 12 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Doctors' Choice Awards
Journal Advertising A Powerful Medium November 2005 According to experts at the AMP, the high level of physicians’ responses to this year’s TDC reaffirms the role medical journal advertising plays as an information source for physicians about pharmaceutical products. Medical journal advertising r...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
Creative Review Each month, this department pays tribute to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. — in combination or as single bran...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Wilson Learning Enhances Performance Measurement Solution Wilson Learning Corp. has released an enhanced version of its Leader Navigator performance measurement system, a multi-rater, 360-degree tool that provides personalized fee...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies GfK Group Integrates U.S. Healthcare Businesses GfK Group has consolidated its U.S. healthcare activities under GfK U.S. HealthCare Companies. This move follows GfK’s acquisition of NOP World, as well as its full acquisition of G...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Patients’ Channel Preferences Vary by Personal Situation In the past few years, patients have become increasingly more informed and sophisticated. They continue to experience increased time pressures and have more access to information about prescription brands than ever thanks to the Internet. T...
By David Zaritsky and Julian Parreño • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Internet Deemed the Most Trusted Media Source by Healthcare Consumers A new study of consumer attitudes toward healthcare information finds that the Internet is regarded as the most trusted media source for consumers, decisively outstripping offline media when consumers want credible health infor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool PharmaVOICE October 2005 Executive Appointments and Promotions in the Healthcare Industry Pharma POOL Dr. Jacqueline Crew Paul Medeiros Dr. John O’Mullane David Wing Schering-Plough Adds Executive Leadership Schering-Plough, a global science-based healthcare company bas...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Management of Customer Relationship Management
The Management of Customer Relationship Management By Elisabeth Pena Villarroel Responding to the customers’ needs is more important than ever for pharmaceutical companies. As patients seek more information and doctors continue to be crunched for time, targeted, meaningful messages that add...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Louis C. Arp Dr. Lyn D. Olson Eisai Announces Executive Appointments Eisai, a pharmaceutical company based in Teaneck, N.J., has appointed Louis C. Arp as VP of production operations and Lyn D. Olson, Ph.D., as VP of quality at its pharmaceutical production and formulation research an...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The numbers are staggering: 70% of all medical prescriptions go unconsumed, leading to $77 billion in excess healthcare costs each year; 30% to 85% of patients may disregard refills, depending on the disease and treatment regimen; and up to 20% of all hospital and nursing home admissions and 125 ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Pharmaceutical Sales Rep Compensation: Time for an overhaul
A look at the minimum and maximum potential for each sales territory can give companies better insight into what their sales reps are actually contributing. This information can provide a way to devise new and fairer compensation patterns that will generate more motivation for sales reps and, ult...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Compliance: Pursuing Solutions Having It All with Candace Kendle Electronic Patient-Reported Outcomes November 2005 Volume 5 Number 11 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Louise Anderson Time to Bundle Up Pharmaceutical companies are facing increased competition and are now taking a lead from other industries, such as telecommunications, and looking to a bundled sales approach. In so doing, the sales organizations are moving to a model of team selli...
By PharmaVoice Team • Jan. 2, 2008
Previous
